Public Release: 30-May-2015 Study identifies possible new combination chemotherapy for patients with advanced prostate cancer University of Texas M. D. Anderson Cancer Center A role for combination therapy using two or more chemotherapy agents at the…

… patients with advanced metastatic castration-resistant prostate cancer (mCRPC) have relied on the … prostate-specific antigen (PSA) and bone-specific alkaline phosphatase (BAP, a marker of prostate cancer … developing tumor-specific biomarkers to identity patients with an aggressive variant of prostate cancer …